- General info
- Available languages
- Background story
Supports up to 69 languages.
Please select a format to view the available languages:
Supports up to 10 OpenType features.
Please select a format to view the available OpenType features:
American graphic designer William Addison Dwiggins' (W.A.D. for short) first typefaces were the Metro family, designed from 1927 onward. The project grew out of Dwiggins' dissatisfaction with the new European sans serif typefaces of the day, such as Futura, Erbar, and Kabel, a feeling he expressed in his seminal book Layout in Advertising. Urged by Mergenthaler Linotype to create a solution for the problem, Dwiggins began a professional relationship that would span over the next few decades.
The first Metro family typeface to be released was Metroblack, brought to market by Linotype in 1929 (Metroblack #2™ the only one of the two versions that Mergenthaler Linotype eventually put into production which is available in digital form). With more of a humanist quality than the geometric styles popular in Europe at the time, Dwiggins drew what he believed to be the ideal sans serif for headlines and advertising copy. Metroblack has a warmer character than the Modernists' achievements, and the type is full of mannered curves and angled terminals (Metroblack also has an astoundingly beautiful Q).
The other weights of the Metro family, Metromedium #2™ and Metrolite #2™, were designed by Mergenthaler Linotype's design office under Dwiggins' supervision.
Despite having been created more than three-quarters of a century ago, the Metro family types have aged well, and remain a popular sans serif family. In 2012 the Metro Nova familiy was created in 26 different weights on the basis of Dwiggins designs by Monotype type designer Toshi Omagari.
Download a free trial
Use this font in your own documents with a free 5 minute trial through SkyFonts. Trials are for evaluation purposes only. Learn more.
This font is currently not available.
You already tried this font within the last 24 hours or you may have exceeded your daily allowance of trials. Learn more.